Table 2 Baseline characteristics of 136 subjects
From: The relationship between HbA1c and ultrasound plaque textures in atherosclerotic patients
Characteristics | Diabetes (n = 66) | Non-diabetes (n = 70) | t | p |
|---|---|---|---|---|
Age, mean (SD) | 67.8 ± 10.0 | 69.4 ± 9.8 | −0.972 | 0.333 |
Male gender, n (%) | 43 (65) | 46 (66) | 0.068 | 0.946 |
Total number of plaques | 2.1 ± 1.2 | 2.0 ± 1.1 | 0.533 | 0.104 |
Hypertension, n (%) | 43 (65) | 44 (63) | 0.277 | 0.783 |
CHD, n (%) | 18 (27.3) | 22 (31.4) | −0.528 | 0.598 |
SBP (mm Hg) | 136.9 ± 19.0 | 139.1 ± 22.0 | −0.642 | 0.522 |
DBP (mm Hg) | 75.8 ± 9.2 | 76.7 ± 12.8 | 0.465 | 0.643 |
BMI (kg/m2) | 23.9 ± 3.1 | 22.0 ± 2.8 | 3.437 | 0.001 |
Total cholesterol (mmol/L) | 4.78 ± 1.20 | 4.46 ± 1.17 | −1.548 | 0.116 |
Triglyceride (mmol/L) | 1.90 ± 1.57 | 1.31 ± 0.89 | 2.677 | 0.009 |
HDL-cholesterol (mmol/L) | 1.05 ± 0.28 | 1.13 ± 0.34 | −1.484 | 0.140 |
LDL-cholesterol (mmol/L) | 3.04 ± 0.97 | 2.86 ± 1.06 | 1.023 | 0.308 |
Lipoprotein A (mg/L) | 211.9 ± 219.2 | 284.9 ± 288.7 | −1.652 | 0.101 |
Apolipoprotein A1(g/L) | 1.29 ± 0.31 | 1.31 ± 0.26 | −0.362 | 0.718 |
Apolipoprotein B100 (g/L) | 1.20 ± 0.47 | 1.17 ± 1.23 | 0.163 | 0.871 |
HbA1c (%) | 8.87 ± 2.25 | 5.50 ± 0.41 | 11.940 | <0.001 |
FPG (mmol/L) | 10.76 ± 4.26 | 5.14 ± 0.70 | 10.611 | <0.001 |
Plaque-IMTmax (mm) | 2.4 ± 0.8 | 2.5 ± 0.8 | −0.635 | 0.527 |